Virtus Medical Group announced that it has received funds in a round of funding led by new investor Shanghai Healthcare Capital Partnership (Limited Partnership) on March 14, 2024. The transaction included participation from new investors Mitsui & Co., Ltd. and Shanghai MediTrust Health Technology Co., Ltd.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7,749 JPY | +0.05% | +2.50% | +46.22% |
03/05 | Mitsui & Co Completes 109 Billion Yen Sale of Paiton Energy | MT |
03/05 | Mitsui & Co to Repurchase and Cancel Up to 40 Million Shares | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+46.22% | 74.7B | |
+26.24% | 68.51B | |
+0.03% | 39.26B | |
+37.03% | 34.13B | |
+30.15% | 31.54B | |
+17.93% | 22.91B | |
+16.06% | 17.56B | |
-1.32% | 13.11B | |
+31.71% | 6.1B | |
-0.45% | 5.83B |
- Stock Market
- Equities
- 8031 Stock
- News Mitsui & Co., Ltd.
- Virtus Medical Group announced that it has received funding from Shanghai Healthcare Capital Partnership (Limited Partnership), Mitsui & Co., Ltd., Shanghai MediTrust Health Technology Co., Ltd.